Zusammenfassung
Die präoperative Evaluation und das perioperative Management der koronaren Herzerkrankung bei Patienten mit vaskulären Eingriffen stellt eine große Herausforderung mit bedeutenden Auswirkungen für das operative Ergebnis dar. Myokardinfarkt und kardialer Tod sind die Hauptursachen der perioperativen Mortalität von Gefäßpatienten. Einen wesentlichen Bestandteil der Risikoreduktion stellt die perioperative medikamentöse Therapie dieser Patienten dar. Anhand der aktuellen Literatur sowie europäischen und amerikanischen Leitlinien wird die Bedeutung von β-Blockern, Statinen und Thrombozytenaggregationshemmern für die Senkung der perioperativen Morbidität beleuchtet.
Abstract
Preoperative evaluation and perioperative management of ischemic cardiac disease are a great challenge in patients undergoing major vascular surgery. They have an important impact on perioperative morbidity and mortality in patients with atherosclerotic disease needing surgery. Perioperative medication is most important in reducing these risks. This review summarizes the current literature and European and American guidelines on the perioperative use of beta-blockers, statins and platelet aggregation inhibitors and their impact on reducing perioperative morbidity.
Literatur
Abraham N, Lemech L, Sandroussi C et al (2005) A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms. J Vasc Surg 41:377–380
Bauer SM, Cayne NS, Veith FJ (2010) New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 51:242–251
Belch JJF, Dormandy J, The Caspar Writing Committee (2010) Results of the randomized, placebo- controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 52:825–833
Boersma E, Poldermans D, Bax JJ et al (2001) Predictors of cardiac events after major vascular surgery: role of clinical characteristics, doputamine echocardiography, and beta-blocker therapy. JAMA 285:1865–1873
Brady AR, Gibbs JS, Greenhalgh RM et al (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41:602–609
Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and meta-analysis. J Intern Med 257:399–414
Cameron CM, Scott DA, McDonald WM, Davies MJ (2007) A review of neuroaxial epidural morbidity: experience of more than 8,000 cases at a single teaching hospital. Anesthesiology 106:997–1002
Christie IW, McCabe S (2007) Major complications of epidural analgesia after surgery: result of a six-year survey. Anaesthesia 62:335–341
Cohen MC, Aretz TH (1999) Historical analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 8:133–139
Cook TM, Counsell D, Wildsmith JA (2009) Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 102:179–190
Crisby M, Nordin-Fredriksson G, Shah PK et al (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103:926–933
Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin, Deutsche Gesellschaft für Innere Medizin, Deutsche Gesellschaft für Chirurgie (2010) Präoperative Evaluation erwachsener Patienten vor elektiven, nichtkardiochirurgischen Eingriffen Gemeinsame Empfehlung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin, der Deutschen Gesellschaft für Chirurgie und der Deutschen Gesellschaft für Innere Medizin. Anaesthesist 59(11):1041–1050
Devereaux PJ, Yang H, Yusuf S et al, POISE Study Group (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847
Dunkelgrun M, Boersma E, Schouten O et al (2009) Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249:921–926
Durazzo AE, Machado FS, Ikeoka DT et al (2004) Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39:967–975
Fleischmann KE, Beckman JA, Buller CE et al (2009) 2009 ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol 54:2102–2128
Fleisher LA, Beckman JA, Brown KA et al (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation 116:1971–1996
Gogarten W et al (2007) Rückenmarksnahe Regionalanästhesie und Thromboembolieprophylaxe/antithrombotische Medikation. (2. überarbeitete) Empfehlung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Anasth Intensivmed 48:109–124
Hindler K, Shaw AD, Samuels J et al (2006) Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105:1260–1272
Juul AB, Wetterslev J, Gluud C et al (2006) Effect of perioperative beta-blockade in patients with diabetes undergoing major non-cardiac surgery: randomized placebo controlled blinded multicentre trial. BMJ 332:1482
Kertai MD, Boersma E, Westerhout CM et al (2004) A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28:343–352
Le Manach Y, Godet G, Coriat P et al (2007) The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 104:1322–1324
Lindenauer PK, Pekow P, Wang K et al (2004) Lipid-lowering therapy and in-hospital mortality after major noncardiac surgery. JAMA 291:2092–2099
Lindenauer PK, Pekow P, Wang K et al (2005) Perioperative beta-blockade therapy and mortality after major noncardiac surgery. N Engl J Med 353:349–361
Mangano DT (1990) Perioperative cardiac morbidity. Anesthesiology 72:153–184
Mangano DT, Layug EL, Wallace A et al (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 333:1713–1720
Merrit JC, Bhatt DL (2004) The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 17:21–27
Monahan TS, Shrikhande GV, Pomposelli FB et al (2005) Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction. J Vasc Surg 41:38–45
Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108:1664–1672
Nowak T, Balzer KM, Böhner H (2009) Die Bedeutung der perioperativen medikamentösen Therapie für das ergebnis gefäßchirurgischer Operationen. Gefässchirurgie 14:301–307
O’Neil-Callahan K, Katsimaglis G, Tepper MR et al (2005) Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45:366–342
Poldermans D, Bax JJ, Kertai MD et al (2003) Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107:1848–1851
Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789–1794
Poldermans D, Boersma E, Bax JJ et al (2001) Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative doputamine echocardiographc findings. J Cardiol 88:1413–1414
Poldermans D, Bax JJ, Boersma E et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 30:2769–2812
Poldermans D, Hoeks SE, Feringa HH (2008) Pre-operative risk assessment and risk reduction before surgery. J Am Coll Cardiol 51:1913–1924
Sipahi I, Tuzcu EM, Wolski KE et al (2007) Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med 147:10–18
Yang H, Raymer K, Butler R et al (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung hin: H. Böhner erhält Vortragshonorare von Sanofi-Aventis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nowak, T., Weisflog, E., Böhner, H. et al. Perioperative Medikation bei arteriellen Operationen. Gefässchirurgie 16, 324–329 (2011). https://doi.org/10.1007/s00772-011-0912-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-011-0912-4